Axa’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-228,827
| Closed | -$4.96M | – | 1229 |
|
|
2022
Q3 | $4.96M | Buy |
228,827
+985
| +0.4% | +$21.3K | 0.02% | 578 |
|
|
2022
Q2 | $6.4M | Buy |
227,842
+94,449
| +71% | +$2.65M | 0.02% | 523 |
|
|
2022
Q1 | $6.15M | Buy |
133,393
+1
| +0% | +$46 | 0.02% | 591 |
|
|
2021
Q4 | $11.2M | Buy |
133,392
+1,591
| +1% | +$134K | 0.03% | 462 |
|
|
2021
Q3 | $8.78M | Buy |
131,801
+4,856
| +4% | +$324K | 0.02% | 535 |
|
|
2021
Q2 | $6.75M | Sell |
126,945
-37,067
| -23% | -$1.97M | 0.02% | 634 |
|
|
2021
Q1 | $7.12M | Buy |
164,012
+3,042
| +2% | +$132K | 0.02% | 609 |
|
|
2020
Q4 | $8.36M | Buy |
160,970
+4,883
| +3% | +$254K | 0.03% | 564 |
|
|
2020
Q3 | $5.1M | Buy |
156,087
+49,444
| +46% | +$1.62M | 0.02% | 617 |
|
|
2020
Q2 | $5.12M | Buy |
+106,643
| New | +$5.12M | 0.02% | 606 |
|